The Hidden Risk: Sarcopenic Obesity One of the growing concerns following GLP-1 discontinuation is sarcopenic obesity
The GLP-1 receptor belongs to the secretin family (class B1) of G protein-coupled receptors, a subfamily of 15 receptors that share a distinctive structural organization
Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures
GLP-1 AGONISTS IN MEN: EFFECTS ON TESTOSTERONE, SPERM, AND SEXUAL FUNCTION Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the management of type 2 diabetes and obesity in recent years
But when you are on a GLP-1 medication, eating less, and potentially losing fluids through GI side effects , sodium becomes critically important
A perfect plan that requires cooking three elaborate meals a day usually does not work well when appetite is low
